Inventor · disambiguated record
Venigalla B. Rao
Also filed as: RAO VENIGALLA · RAO VENIGALLA B · RAO VENIGALLA BASAVESWARA
23 granted patents·4 pending applications·39 citations·filing 2004–2023
93Inventor score
Top patents by PatentIndex Score
27 records- 0194US11401530B2Bacteriophage-based artificial viruses for human genome remodelingUNIV AMERICA CATHOLIC·Filed 2021·Granted Aug 2, 2022·6 cites·3 claims
- 0293US11155835B2Prokaryotic-eukaryotic hybrid viral vector for delivery of large cargos of genes and proteins into human cellsUNIV AMERICA CATHOLIC·Filed 2020·Granted Oct 26, 2021·4 cites·27 claims
- 0389US9580477B2Approach to produce HIV-1 GP140 envelope protein trimersUNIV AMERICA CATHOLIC·Filed 2015·Granted Feb 28, 2017·3 cites·90 claims
- 0486US9944679B2Authentic trimeric HIV-1 envelope glycoproteins comprising a long linker and tagUNIV AMERICA CATHOLIC·Filed 2015·Granted Apr 17, 2018·2 cites·22 claims
- 0586US9850288B2Method of purifying authentic trimeric HIV-1 envelope glycoproteins comprising a long linker and tagUNIV AMERICA CATHOLIC·Filed 2015·Granted Dec 26, 2017·2 cites·24 claims
- 0686US9834583B2Authentic trimeric HIV-1 GP140 envelope glycoproteins comprising a long linker and tagUNIV AMERICA CATHOLIC·Filed 2015·Granted Dec 5, 2017·2 cites·35 claims
- 0786US9163262B2In vitro and in vivo delivery of genes and proteins using the bacteriophage T4 DNA packaging machineUNIV AMERICA CATHOLIC·Filed 2013·Granted Oct 20, 2015·4 cites·20 claims
- 0885US8148130B2T4 bacteriophage bound to a substrateALVING CARL R·Filed 2008·Granted Apr 3, 2012·5 cites·19 claims
- 0977US9328149B2Mutated and bacteriophage T4 nanoparticle arrayed F1-V immunogens from Yersinia pestis as next generation plague vaccinesUNIV AMERICA CATHOLIC·Filed 2014·Granted May 3, 2016·5 cites·18 claims
- 1075US9187765B2In vitro and In vivo delivery of genes and proteins using the bacteriophage T4 DNA packaging machineUNIV AMERICA CATHOLIC·Filed 2014·Granted Nov 17, 2015·1 cites·13 claims
- 1173US11219686B2Dual anthrax-plague vaccines that can protect against two tier-1 bioterror pathogens, bacillus anthracis and yersinia pestisUNIV AMERICA CATHOLIC·Filed 2019·Granted Jan 11, 2022·0 cites·15 claims
- 1271US12241080B2Bacteriophage-based artificial viruses for human genome remodelingUNIV AMERICA CATHOLIC·Filed 2021·Granted Mar 4, 2025·0 cites·6 claims
- 1371US8685694B2Methods and compositions comprising bacteriophage nanoparticlesRAO VENIGALLA BASAVESWARA·Filed 2004·Granted Apr 1, 2014·4 cites·35 claims
- 1470US12037597B2Prokaryotic-eukaryotic hybrid viral vector for delivery of large cargos of genes and proteins into human cellsUNIV AMERICA CATHOLIC·Filed 2021·Granted Jul 16, 2024·0 cites·4 claims
- 1570US10005819B2Method of purifying authentic trimeric HIV-1 GP140 envelope glycoproteins comprising a long linker and tagUNIV AMERICA CATHOLIC·Filed 2017·Granted Jun 26, 2018·0 cites·20 claims
- 1669US10407470B2Method of inducing an immune response against human immunodeficiency virus comprising administering immunogenic compositions comprising authentic trimeric HIV-1 envelope glycoproteins containing a long linker and tagUNIV AMERICA CATHOLIC·Filed 2018·Granted Sep 10, 2019·0 cites·31 claims
- 1769US8802418B2Protein and nucleic acid delivery vehicles, components and mechanisms thereofRAO VENIGALLA B·Filed 2011·Granted Aug 12, 2014·1 cites·52 claims
- 1867US9523101B2Protein and nucleic acid delivery vehicles, components and mechanisms thereofUNIV AMERICA CATHOLIC·Filed 2014·Granted Dec 20, 2016·0 cites·14 claims
- 1965US2023355738A1Bacteriophage-based, needle and adjuvant-free, mucosal covid-19 vaccineUNIV AMERICA CATHOLIC·Filed 2023·Application pending·0 cites
- 2064US9365867B2Protein and nucleic acid delivery vehicles, components and mechanisms thereofUNIV AMERICA CATHOLIC·Filed 2013·Granted Jun 14, 2016·0 cites·24 claims
- 2163US2023026666A1Engineered bacteriophage t4 nanoparticles as a potential targeted activator of hiv-1 latency in cd4+ human t-cellsUNIV AMERICA CATHOLIC·Filed 2022·Application pending·0 cites
- 2262US9975924B2Approach to produce HIV-1 GP140 envelope protein trimersUNIV AMERICA CATHOLIC·Filed 2015·Granted May 22, 2018·0 cites·46 claims
- 2360US10556002B2Dual anthrax-plague vaccines that can protect against two tier-1 bioterror pathogens, Bacillus anthracis and Yersinia pestisUNIV AMERICA CATHOLIC·Filed 2018·Granted Feb 11, 2020·0 cites·10 claims
- 2457US9328145B2Designing a soluble full-length HIV-1 gp41 trimerUNIV AMERICA CATHOLIC·Filed 2013·Granted May 3, 2016·0 cites·12 claims
- 2552US2022184205A1Universal bacteriophage t4 nanoparticle platform to design multiplex sars-cov-2 vaccine candidates by crispr engineeringUNIV AMERICA CATHOLIC·Filed 2021·Application pending·0 cites
- 2649US9701722B2Designing a soluble full-length HIV-1 gp41 trimerUNIV AMERICA CATHOLIC·Filed 2016·Granted Jul 11, 2017·0 cites·5 claims
- 2742US2019330643A1Engineering of bacteriophages by genome editing using the crispr-cas9 systemUNIV AMERICA CATHOLIC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Venigalla B. Rao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →